02.12.2012 Views

Estrogen Receptor Null Mice - Endocrine Reviews

Estrogen Receptor Null Mice - Endocrine Reviews

Estrogen Receptor Null Mice - Endocrine Reviews

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

June, 1999 ESTROGEN RECEPTOR NULL MICE 395<br />

direct loss of or simply enhanced by the concurrent decrease<br />

in PRL signaling.<br />

Interestingly, the extremely low levels of PRL mRNA in<br />

the anterior pituitary of the �ERKO female are even significantly<br />

less than that observed 14 days after ovariectomy in<br />

the wild-type (282). Therefore, the loss of ER� during development<br />

and differentiation of the lactotrophs in the anterior<br />

pituitary has resulted in a phenotype that is more<br />

severe than that induced by postpubertal ovariectomy, possibly<br />

due to a decrease in lactotroph cell number. It has been<br />

proposed that the lactotroph and somatotroph cell types of<br />

the adult anterior pituitary may be derived from a common<br />

cell that expresses both the genes for GH and PRL during<br />

development (reviewed in Ref. 410). The factors that may be<br />

involved in the terminal differentiation of this stem cell into<br />

a distinct cell type secreting only one of the respective hormones<br />

remain elusive. Because the appearance of the ER and<br />

the ontogeny of PRL expression appear to coincide in the<br />

developing pituitary, estrogen action has been proposed as<br />

a possible factor (410–412). However, a defect in the cell<br />

lineage of the lactotrophs that may be expected due to a loss<br />

of ER� action was not apparent in the �ERKO, as immunostaining<br />

for both PRL and GH localized expression of the<br />

genes to distinct cell types (282).<br />

Furthermore, estrogen has also been shown to stimulate<br />

proliferation of the lactotrophs and PRL-secreting cell lines<br />

(reviewed in Ref. 339). Therefore, since the marked difference<br />

in PRL mRNA levels observed between the �ERKO female<br />

and the ovariectomized wild-type is not apparently due to a<br />

defect in the differentiation of the lactotrophs, it may possibly<br />

be due to a decreased number of lactotrophs in the anterior<br />

pituitary of the �ERKO. Scully et al. (282) provided evidence<br />

against this hypothesis, by once again employing immunohistochemical<br />

staining to illustrate only a modest decrease in<br />

lactotroph cells in the anterior pituitary of the �ERKO mice.<br />

Therefore, ER� action does not appear to be required for<br />

either differentiation or proliferation of the lactotrophs in the<br />

mouse anterior pituitary. However, a recent report by Chun<br />

et al. (413) has illustrated a distinct contrast in the level of<br />

occupied ER required to elicit proliferation and that required<br />

for PRL synthesis in PR1 cells, a PRL-secreting cell line.<br />

Whereas approximately 50% of the cellular pool of ER was<br />

required to be complexed with estradiol for half-maximal<br />

stimulation of the PRL gene, only 0.1% was required to<br />

induce cellular proliferation (413). These results suggest that<br />

the mechanisms required for estrogen-induced lactotroph<br />

proliferation are hypersensitive in this cell line compared<br />

with the mechanisms involved in regulation of the PRL gene<br />

(413). Therefore, it is possible that the small amount of the<br />

active ER� splicing variant known to be present in the<br />

�ERKO (see Section II.C.) has allowed for sufficient estrogen<br />

signaling and lactotroph proliferation during develpment,<br />

resulting in the apparent lack of a somewhat expected phenotype<br />

of decreased lactotroph cell number in the pituitary<br />

of �ERKO mice.<br />

B. Behavior<br />

There are obvious effects of the gonadal steroids on sexual<br />

behavior in vertebrates; however, a more defined knowledge<br />

of these actions has become evident from a series of classical<br />

experimental schemes. These laboratory studies often relied<br />

on perinatal castration and/or developmental exposure to<br />

exogenous steroids followed by studies of the activational<br />

abilities of the different steroids during adulthood. The majority<br />

of such investigations have been carried out in the rat,<br />

but similar results have been described in other species (345,<br />

414). Breifly, studies on sexual behavior in the rat have<br />

shown that 1) castration on the day of birth results in a<br />

feminized adult male that exhibits a female pattern of behavioral<br />

responses when treated with estradiol and progesterone,<br />

and 2) neonatal testosterone or estradiol treatment of<br />

a female results in a masculinized adult that exhibits a malelike<br />

pattern of behaviors and is refractory to estradiol and<br />

progesterone (131, 337). The culmination of the data collected<br />

from such experimental schemes has led to the conclusion<br />

that testosterone secreted from the perinatal testes during a<br />

critical developmental window results in permanent changes<br />

in the hypothalamic nuclei of the brain that mediate male<br />

sexual behavior. However, the data indicating that developmental<br />

exposure to estradiol results in an adult phenotype<br />

that is similar to that elicited by testosterone suggest that<br />

many of the masculinizing effects of perinatal testosterone<br />

may be via local aromatization of the hormone to estradiol<br />

and subsequent activation of the ER signaling pathway (reviewed<br />

in Refs. 406 and 407). In addition, estradiol is also<br />

necessary for normal development of the female brain, although<br />

in lower amounts (131). Therefore, sex steroid-mediated<br />

sexual differentiation of the various regions of the<br />

brain that are critical to behavior relies not only on the nature<br />

of the steroid ligand, but also on the dose and timing of<br />

exposure (348).<br />

Before the availability of the �ERKO mouse, McCarthy et<br />

al. (415) employed an elaborate technique of infusing anti-<br />

ER� oligodeoxynucleotides into the neonatal rat hypothalamus<br />

to elucidate a direct role for ER� in the sexual differentiation<br />

of the female brain. This experimental scheme was<br />

based on the hypothesis that the presence of specific ER�<br />

antisense oligodeoxynucleotides in the hypothalamus would<br />

interfere with proper expression of the ER� gene during a<br />

critical period of differentiation (415). The experimental<br />

groups included neonatal rats treated with testosterone plus<br />

or minus the infusion of the ER� antisense oligodeoxynucleotides.<br />

As adults, those females infused with the ER� antisense<br />

oligodeoxynucleotides exhibited more female sexual<br />

behavior compared with those treated with androgen alone.<br />

The investigators thereby concluded that the reduced ER�<br />

expression protected the infused female rats from the masculinizing<br />

effects of testosterone exposure (415), providing<br />

strong evidence that local aromatization and subsequent estradiol<br />

activation of the ER� pathway plays a primary role<br />

in the masculinization of the rat brain. However, the experimental<br />

scheme of McCarthy et al. does not allow for a direct<br />

comparison with the �ERKO female, due to the caveats discussed<br />

(see Section II.C.1). It is important to recognize that the<br />

�ERKO are deficient in ER� throughout development,<br />

whereas McCarthy’s scheme produced a lack of ER� action<br />

that was only transient and most likely not as complete.<br />

The use of technologies to target individual genes has<br />

created numerous models available for studies in the behav-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!